Cutaneous lymphoma of the tarsus in cats: 23 cases (2000-2012).

Holly D Burr
Holly D Burr
Cummings School of Veterinary Medicine
John H Keating
John H Keating
Department of Clinical Sciences
United States
Craig A Clifford
Craig A Clifford
Red Bank Veterinary Hospital
Tinton Falls | United States

J Am Vet Med Assoc 2014 Jun;244(12):1429-34

Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, MA 01536.

Objective: To determine features of lymphoma of the tarsus in cats.

Design: Multi-institutional retrospective study.

Animals: 23 cats with cutaneous lymphoma of the tarsus.

Procedures: Veterinary oncologists were requested to submit cases fitting the following criteria: histologically or cytologically confirmed lymphoma with a location at or near the tarsus and described as subcutaneous or mass-like. Data regarding breed, sex, age, FeLV and FIV status, and reason for evaluation were collected. Results of staging tests, location of the tumor, immunophenotype, and histopathologic description were recorded. Type of treatments, outcome, survival time, presence or absence of progressive disease, and cause of death or reason for euthanasia were also recorded.

Results: Most cats were older, with a median age of 12 years (range, 7 to 18 years). No association with positive retroviral status was found. Popliteal lymph node involvement at diagnosis was reported in 5 cats, and a suspicion of lymphoma at a different site on the basis of results of abdominal ultrasonography was reported in 4 cats. Treatments were variable and included corticosteroids alone (n = 2), chemotherapy (9), radiation and chemotherapy (7), or surgery with or without chemotherapy (5). Thirteen cats were reported to have lymphoma at a different site at the time of last follow-up, death, or euthanasia. Median survival time for all cats in the study was 190 days (range, 17 to 1,011 days).

Conclusions And Clinical Relevance: Results suggested that tarsal lymphoma is an uncommon manifestation of lymphoma in cats, and in this study was most commonly nonepitheliotropic and of high grade as determined on histologic evaluation. Systemic involvement was identified; therefore, thorough staging is recommended prior to initiating treatment. Future studies are warranted to evaluate effective treatment protocols.

Download full-text PDF

Source Listing

Still can't find the full text of the article?

Sign up to send a request to the authors directly.
June 2014
52 Reads

Publication Analysis

Top Keywords

survival time
lymphoma site
reported cats
cats study
cutaneous lymphoma
lymphoma tarsus
thirteen cats
site basis
basis abdominal
abdominal ultrasonography
suspicion lymphoma
cats suspicion
involvement diagnosis
diagnosis reported
chemotherapy thirteen
ultrasonography reported
cats treatments
corticosteroids chemotherapy

Similar Publications

miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway.

J Exp Clin Cancer Res 2018 Sep 21;37(1):235. Epub 2018 Sep 21.

Department of Pathology, the University of Tennessee Health Science Center, 19 S. Manassas St., Rm. 266, Memphis, TN, 38163, USA.

Background: We previously reported that miR-203 functions as a tumor suppressor in ovarian cancer cells by directly targeting transcription factor Snai2 and inhibiting epithelial to mesenchymal transition (EMT), whereas BIRC5/survivin promotes EMT. In this study, we tested our hypothesis that miR-203 inhibits ovarian tumor metastasis by suppressing EMT through targeting BIRC5, using an orthotopic ovarian cancer mouse model.

Methods: We overexpressed miR-203 in ovarian cancer SKOV3 and OVCAR3 cells using a lentiviral vector and examined cell migration and invasion using transwell plates. Read More

View Article
September 2018
12 Reads

An evaluation of patient's decisions regarding dental prosthetic treatment.

J Indian Prosthodont Soc 2016 Oct-Dec;16(4):366-371

Department of Prosthodontics and Implantology, VSPM Dental College, Nagpur, Maharashtra, India.

Introduction: For fabricating dental prostheses that meet patients' demands and have good longevity and function, appropriate treatment planning and decision-making are required. Therefore, not only technical skills and clinical judgment of the dentist are needed, but also patients' attitude toward treatment plays a critical role in posttreatment satisfaction.

Aim: The aim of this study is to investigate the factors affecting decision-making and the selection of dental prosthesis by the patients. Read More

View Article
October 2016
8 Reads
2 PubMed Central Citations(source)

All-Dielectric Colored Metasurfaces with Silicon Mie Resonators.

ACS Nano 2016 08 8;10(8):7761-7. Epub 2016 Aug 8.

Aix Marseille Univ, CNRS, Centrale Marseille, Institut Fresnel , 13013 Marseille, France.

The photonic resonances hosted by nanostructures provide vivid colors that can be used as color filters instead of organic colors and pigments in photodetectors and printing technology. Metallic nanostructures have been widely studied due to their ability to sustain surface plasmons that resonantly interact with light. Most of the metallic nanoparticles behave as point-like electric multipoles. Read More

View Article
August 2016
5 Reads
10 PubMed Central Citations(source)
12.88 Impact Factor

Development and characterization of an antibody-labeled super-paramagnetic iron oxide contrast agent targeting prostate cancer cells for magnetic resonance imaging.

PLoS One 2014 12;9(5):e97220. Epub 2014 May 12.

Thunder Bay Regional Research Institute, Ontario, Canada; Department of Physics, Lakehead University, Thunder Bay, Ontario, Canada.

In this study we developed, characterized and validated in vitro a functional superparagmagnetic iron-oxide based magnetic resonance contrast agent by conjugating a commercially available iron oxide nanoparticle, Molday ION Rhodamine-B Carboxyl (MIRB), with a deimmunized mouse monoclonal antibody (muJ591) targeting prostate-specific membrane antigen (PSMA). This functional contrast agent is intended for the specific and non-invasive detection of prostate cancer cells that are PSMA positive, a marker implicated in prostate tumor progression and metastasis. The two-step carbodiimide reaction used to conjugate the antibody to the nanoparticle was efficient and we obtained an elemental iron content of 1958 ± 611 per antibody. Read More

View Article
June 2015
18 Reads
10 PubMed Central Citations(source)
3.23 Impact Factor

Fanconi-Bickel syndrome versus osteogenesis imperfeeta: An Iranian case with a novel mutation in glucose transporter 2 gene, and review of literature.

Indian J Hum Genet 2013 Jan;19(1):84-6

Department of Medical Genetics, Sarem Cell Research Center, Sarem Women Hospital, Tehran, Iran.

Fanconi-Bickel syndrome is an extremely rare hereditary metabolic disease, characterized by hepatomegaly due to glycogen storage, refractory hypophosphatemic rickets, marked growth retardation and proximal renal tubular acidosis. Recurrent bone fractures are one of the hallmark findings. It is a single gene disorder; the responsible gene belongs to the facilitative glucose transporters 2 (GLUT2) family gene or (SLC2A2) mapped to the q26. Read More

View Article
January 2013
10 Reads
1 PubMed Central Citation(source)